(Q46318048)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Esther M de Kruijf

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Charla C Engels

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Willemien van de Water

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Esther Bastiaannet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Vincent T H B M Smit

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Cornelis J H van de Velde

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Gerrit Jan Liefers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

7 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

355-364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-013-2752-2

29 February 2020

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Cancer despite immunosurveillance: immunoselection and immunosubversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Gene-expression signatures in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2752-2

10.1007/S10549-013-2752-2

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24197659%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference